Biogen to acquire RayThera for $1 billion
18/06/2026 24:05
Biogen to acquire RayThera for $1 billion June 17 (Reuters) - Biogen BIIB.O said on Wednesday it would acquire drug discovery company RayThera for $1 billion, including milestone payments.
(Reporting by Ananya Palyekar in Bengaluru)
Recent news on Biogen
See all newsHealth Rounds: Old cancer drug may help restore fertility for certain women
U.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
Biogen rises; co scales back drug programs acquired through $5.6 bln Apellis deal
Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout